An interventional study of Extracorporeal Shockwave therapy and Balanced low-calorie diet in Obesity, Abdominal, sponsored by Cairo University. Completed at 1 site in Egypt. Open to female participants aged 45 Years to 60 Years. Per ClinicalTrials.gov, last updated 2024-07-22.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
Almost postmenopausal women store significant extra visceral adipose tissue with unexplained mechanism, yet. Postmenopausal obese women with excess abdominal obesity have raised metabolic risk of numerous cardiovascular diseases, which negatively influence health policy concern. Therefore, actual need to recommend non-invasive approach that cover this lack of quantitative knowledge in clinical management of obese postmenopausal women.
Postmenopausal women are usually troubled by increasing weight and waist circumference caused by obesity and androcidal fat redistribution. Abdominal adiposity, defined as a waist circumference ≥88cm in women, measured in the upright position, plus significant elevated lipid profile values. In postmenopausal women, a higher level of physical activity was associated with a more optimal body composition, including lower adiposity and higher lean mass. Management of abdominal obesity involves different techniques i.e., dietary management, exercise therapy, even lifestyle management, and pharmacological management, and surgical interventions. Extracorporeal shockwave provides cavitation phenomena that may facilitate better management of abdominal obesity. Thus, current study will be conducted to investigate effect of extracorporeal shockwave on abdominal adiposity and lipid profile in obese post-menopausal women.
274 studies on the registry are indexed under Obesity, Abdominal; 44 are open to participants now.
This study's enrollment of 60 is close to the median of 60 across 216 interventional studies indexed under Obesity, Abdominal.
Browse Obesity, Abdominal studies →Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
30 participants will receive Extracorporeal Shockwave (one session per week for 6 weeks), in addition to a balanced low-calorie diet (1500 k/cal for 6 weeks).
Other: Extracorporeal Shockwave therapy · Other: Balanced low-calorie diet
30 participant will receive Balanced low-calorie diet (1500 k/cal for 6 weeks), only.
Other: Balanced low-calorie diet
2000 shots, 120mJ pulse energy setting, 3 bar pressure, and 15 Hz for 15 minute per session.
1500 k/cal for 6 weeks
Waist/ hip ratio
anthropometric outcome measure for abdominal adiposity
Time frame: Pretreatment and Posttreatment of six weeks study protocol.
Skin fold caliper
subcutaneous fat outcome measure
Time frame: Pretreatment and Posttreatment of six weeks study protocol.
Lipid profile
Low-density lipoprotein, High-density lipoprotein, and triglyceride laboratory outcome measures.
Time frame: Pretreatment and Posttreatment of six weeks study protocol.
Plan to share: No — Will Share whole raw data, therapeutic protocol details for future systematic review and/ or meta-analysis. wish to be valuable
No publications or documents are linked to this record.
This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cairo University